Company: ANIX
Filing Date: 2025-09-10
Form Type: 10-Q
Source: 0001493152-25-013000
Chunk: 7

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
 Stock
    options issued to consultants 
     -  
     -  
     101  
     -  
     -  
     101  
     -  
     101 
  
    Common
    stock issued in an at-the-market offering, net of offering expenses of $139 
     785,290  
     8  
     2,976  
     -  
     -  
     2,984  
     -  
     2,984 
  
    Common
stock issued in an at-the-market offering, net of offering expenses 
     785,290  
     8  
     2,976  
     -  
     -  
     2,984  
     -  
     2,984 

    Common
    stock issued upon exercise of stock options 
     123,999  
     1  
     317  
     -  
     -  
     318  
     -  
     318 
  
    Common
    stock issued to consultants 
     89,336  
     1  
     254  
     -  
     -  
     255  
     -  
     255 
  
    Common
    stock issued pursuant to an employee stock purchase plan 
     2,616  
     -  
     7  
     -  
     -  
     7  
     -  
     7 
  
    Net
    loss 
     -  
     -  
     -  
     (9,671) 
     -  
     (9,671) 
     (114) 
     (9,785)
  
    Balance,
    July 31, 2024 
     32,146,460  
    $321  
    $259,317  
    $(237,867) 
    $-  
    $21,771  
    $(1,080) 
    $20,691 
  
    Balance 
     32,146,460  
    $321  
    $259,317  
    $(237,867) 
    $-  
    $21,771  
    $(1,